InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth Eleventh consecutive quarter of sequential profitable revenue growth Annualized revenue run rate of...

InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1) Fourth quarter 2021 Revenue and Adjusted EBITDA2 of $33 million and $9 million, representing an increase of almost 200% and...

InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better” Marking the First Major Consolidation in Pharmaceutical Grade Medical Cannabis Market Acquisition is Expected to be Accretive Strengthen...

InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue – 3 Times YoY and 24% QoQ Growth Estimated revenue reaches over CAD$31 million (a record NIS 77 million) Anticipates continued...

InterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million – 3 Times YOY and 36% QOQ Growth Achieved a number of firsts and records including: Seventh consecutive quarter...